17 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
appropriate.
(c) Research Analyst Independence. The Company acknowledges that the Agent’s research analysts and research departments are required
6-K
EX-99.2
IPHA
Innate Pharma
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
) independence of financial years, and in conformity with the general rules for the preparation and presentation of consolidated financial statements
6-K
EX-1.1
IPHA
Innate Pharma
26 Apr 23
Current report (foreign)
4:02pm
appropriate.
(c) Research Analyst Independence. The Company acknowledges that the Agent’s research analysts and research departments are required
6-K
EX-99.2
umwmi2a7zh bd1v
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-99.2
9eo2u1
15 Sep 21
Innate Pharma Reports First Half 2021 Financial Results and Business Update
6:07am
6-K
EX-99.2
0ujj1haftq
8 Sep 20
Innate Pharma Reports First Half 2020 Financial Results and Business Update
6:10am
20-F
xjd7918d 1r8qth0tb
24 Apr 20
Annual report (foreign)
10:43am
424B4
91e92
18 Oct 19
Prospectus supplement with pricing info
4:08pm
F-1/A
dswvub9
4 Oct 19
Registration statement (foreign) (amended)
4:56pm
F-1
2t6lqi81uq099v
20 Sep 19
Registration statement (foreign)
4:08pm
DRS/A
l94qpagcvae 6l1w0
30 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
nd8le1
19 Jul 19
Draft registration statement (amended)
12:00am
DRS
i3nsvmv
10 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next